Company

Aroa Biosurgery Limited

Headquarters: Auckland, New Zealand

CEO: Dr. Brian Ward

ASX: ARX +2.36%

Market Cap

A$236.4 Million

AUD as of July 1, 2024

US$157.4 Million

Market Cap History

Aroa Biosurgery Limited market capitalization over time

Evolution of Aroa Biosurgery Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Aroa Biosurgery Limited

Detailed Description

Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and selling of medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Aroa Biosurgery Limited has the following listings and related stock indices.


Stock: ASX: ARX wb_incandescent

Details

Headquarters:

2 Kingsford Smith Place

Airport Oaks Auckland Airport PO Box 107111

Auckland, 2150

New Zealand

Phone: 64 9 869 3035